KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
58 hedge funds and large institutions have $54M invested in Kinnate Biopharma Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% less capital invested
Capital invested by funds: $121M → $54M (-$67.4M)
67% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 21
Holders
58
Holding in Top 10
5
Calls
$30K
Puts
$3K
Top Buyers
| 1 | +$588K | |
| 2 | +$484K | |
| 3 | +$428K | |
| 4 |
Renaissance Technologies
New York
|
+$235K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$202K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$1.49M | |
| 3 | -$1.4M | |
| 4 |
Millennium Management
New York
|
-$483K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$478K |